1 – 10 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome : a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry
(
- Contribution to journal › Article
-
Mark
Rationale and design of INFINITY-SWEDEHEART : A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
(
- Contribution to journal › Article
-
Mark
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART) : a single-blind, non-inferiority, registry-based, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
(
- Contribution to journal › Article
-
Mark
A randomised trial of selective intracoronary hypothermia during primary PCI
(
- Contribution to journal › Article
- 2023
-
Mark
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve : A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve
(
- Contribution to journal › Article
-
Mark
Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis From SCAAR
(
- Contribution to journal › Article
-
Mark
Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention : A Substudy of VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients : PROSPECT II
(
- Contribution to journal › Article